Targeting ubiquitin-activating enzyme induces ER stress–mediated apoptosis in B-cell lymphoma cells

Scott Best(Oregon Health & Science University), Alexey V. Danilov(City of Hope), Allison Berger(Takeda (United States)), Taylor Hashiguchi(Oregon Health & Science University), Cody Paiva(Oregon Health & Science University), Adam S. Kittai(Icahn School of Medicine at Mount Sinai), Nur Bruss(Oregon Health & Science University), Craig Okada(Oregon Health & Science University), Tingting Liu(Oregon Health & Science University)
Blood Advances
January 7, 2019
10.1182/bloodadvances.2018026880
Cited by 55

Related Papers

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
|Nature|2009|2k
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB–dependent lymphoma
|Blood|2010|323
Immune Checkpoint Inhibitors in Organ Transplant Patients
|Journal of Immunotherapy|2017|150
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
|The Lancet Haematology|2024|134
Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia
|JACC CardioOncology|2023|107